{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:21:00Z","timestamp":1740144060849,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40262-024-01455-3","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:32:20Z","timestamp":1731652340000},"page":"1769-1776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetics of Enteral Lormetazepam in Mechanically Ventilated ICU Patients with COVID-19: An Adjunct Sedative Study"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3367-6333","authenticated-orcid":false,"given":"Jos L. M. L.","family":"le Noble","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly N.","family":"Shudofsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Foudraine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieko","family":"Punt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paddy K. J.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"1455_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253778","volume":"16","author":"AN Flinspach","year":"2021","unstructured":"Flinspach AN, Booke H, Zacharowski K, Balaban \u00dc, Herrmann E, Adam EH. High sedation needs of critically ill COVID-19 ARDS patients\u2014a monocentric observational study. PLoS ONE. 2021;16: e0253778. https:\/\/doi.org\/10.1371\/journal.pone.0253778.","journal-title":"PLoS ONE"},{"key":"1455_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1097\/CCM.0000000000005053","volume":"49","author":"K Wongtangman","year":"2021","unstructured":"Wongtangman K, Santer P, Wachtendorf LJ, Azimaraghi O, Baedorf Kassis E, Teja B, et al. Association of sedation, coma, and in-hospital mortality in mechanically ventilated patients with coronavirus disease 2019-related acute respiratory distress syndrome: a retrospective cohort study. Crit Care Med. 2021;49:1524\u201334. https:\/\/doi.org\/10.1097\/CCM.0000000000005053.","journal-title":"Crit Care Med"},{"key":"1455_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10184091","author":"B Weiss","year":"2021","unstructured":"Weiss B, Hilfrich D, Vorderw\u00fclbecke G, Heinrich M, Grunow JJ, Paul N, et al. Outcomes in critically ill patients sedated with intravenous lormetazepam or midazolam: a retrospective cohort study. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10184091.","journal-title":"J Clin Med"},{"key":"1455_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/372740","volume":"2014","author":"A Luetz","year":"2014","unstructured":"Luetz A, Weiss B, Spies CD. Intravenous lormetazepam during sedation weaning in a 26-year-old critically ill woman. Case Rep Crit Care. 2014;2014: 372740. https:\/\/doi.org\/10.1155\/2014\/372740.","journal-title":"Case Rep Crit Care."},{"key":"1455_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1254\/fpj.98.5_399","volume":"98","author":"M Ozawa","year":"1991","unstructured":"Ozawa M, Nakada Y, Sugimachi K, Akai T, Yamaguchi M. Interaction of the hypnotic lormetazepam with central benzodiazepine receptor subtypes omega 1, omega 2 and omega 3. Nihon Yakurigaku Zasshi. 1991;98:399\u2013408. https:\/\/doi.org\/10.1254\/fpj.98.5_399.","journal-title":"Nihon Yakurigaku Zasshi."},{"key":"1455_CR6","first-page":"675","volume":"40","author":"A Doenicke","year":"1991","unstructured":"Doenicke A, Dorow R. T\u00e4uber U [The pharmacokinetics of lormetazepam following cimetidine]. Anaesthesist. 1991;40:675\u20139.","journal-title":"Anaesthesist"},{"key":"1455_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF03189433","volume":"4","author":"M H\u00fcmpel","year":"1979","unstructured":"H\u00fcmpel M, Illi V, Milius W, Wendt H, Kurowski M. The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C. Eur J Drug Metab Pharmacokinet. 1979;4:237\u201343. https:\/\/doi.org\/10.1007\/BF03189433.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1455_CR8","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00702-020-02209-8","volume":"127","author":"R Horowski","year":"2020","unstructured":"Horowski R. Dependence liability of lormetazepam: Are all benzodiazepines equal? The case of the new i.v. lormetazepam for anesthetic procedures. J Neural Transm (Vienna). 2020;127:1107\u201315.","journal-title":"J Neural Transm (Vienna)"},{"key":"1455_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13318-020-00668-8","volume":"46","author":"S Deb","year":"2021","unstructured":"Deb S, Arrighi S. Potential effects of COVID-19 on cytochrome P450-mediated drug metabolism and disposition in infected patients. Eur J Drug Metab Pharmacokinet. 2021;46:185\u2013203. https:\/\/doi.org\/10.1007\/s13318-020-00668-8.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1455_CR10","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1097\/ALN.0000000000003288","volume":"132","author":"M Luo","year":"2020","unstructured":"Luo M, Cao S, Wei L, Tang R, Hong S, Liu R, et al. Precautions for intubating patients with COVID-19. Anesthesiology. 2020;132:1616\u20138. https:\/\/doi.org\/10.1097\/ALN.0000000000003288.","journal-title":"Anesthesiology"},{"key":"1455_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.accpm.2020.04.010","volume":"39","author":"JF Payen","year":"2020","unstructured":"Payen JF, Chanques G, Futier E, Velly L, Jaber S, Constantin JM. Sedation for critically ill patients with COVID-19: Which specificities? One size does not fit all. Anaesth Crit Care Pain Med. 2020;39:341\u20133. https:\/\/doi.org\/10.1016\/j.accpm.2020.04.010.","journal-title":"Anaesth Crit Care Pain Med."},{"key":"1455_CR12","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/ALN.0000000000003296","volume":"132","author":"L Meng","year":"2020","unstructured":"Meng L, Qiu H, Wan L, Ai Y, Xue Z, Guo Q, et al. Intubation and ventilation amid the COVID-19 outbreak: Wuhan\u2019s experience. Anesthesiology. 2020;132:1317\u201332. https:\/\/doi.org\/10.1097\/ALN.0000000000003296.","journal-title":"Anesthesiology"},{"key":"1455_CR13","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/ALN.0000000000003300","volume":"132","author":"HF Zhang","year":"2020","unstructured":"Zhang HF, Bo L, Lin Y, Li FX, Sun S, Lin HB, et al. Response of Chinese anesthesiologists to the COVID-19 outbreak. Anesthesiology. 2020;132:1333\u20138. https:\/\/doi.org\/10.1097\/ALN.0000000000003300.","journal-title":"Anesthesiology"},{"key":"1455_CR14","unstructured":"Ema ICH. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-q2r2-validation-analytical-procedures-step-2b_en.pdf. Accessed 2 Mar 2024"},{"key":"1455_CR15","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1097\/01.ccm.0000084806.15352.da","volume":"31","author":"SN de Wildt","year":"2003","unstructured":"de Wildt SN, de Hoog M, Vinks AA, van der Giesen E, van den Anker JN. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients. Crit Care Med. 2003;31:1952\u20138. https:\/\/doi.org\/10.1097\/01.ccm.0000084806.15352.da.","journal-title":"Crit Care Med"},{"key":"1455_CR16","unstructured":"NIH. Compound summary lormetazepam. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Lormetazepam. Accessed 15 Mar 2024"},{"key":"1455_CR17","doi-asserted-by":"publisher","unstructured":"Rozenveld E, Punt N, van Faassen M, van Beek AP, Touw DJ. Pharmacokinetic modeling of hydrocortisone by including protein binding to corticosteroid-binding globulin. Pharmaceutics. 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14061161","DOI":"10.3390\/pharmaceutics14061161"},{"key":"1455_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00003-22","volume":"66","author":"R Abolhassani-Chimeh","year":"2022","unstructured":"Abolhassani-Chimeh R, Akkerman OW, Saktiawati AMI, Punt NC, Bolhuis MS, Subronto YW, et al. Population pharmacokinetic modelling and limited sampling strategies for therapeutic drug monitoring of pyrazinamide in patients with tuberculosis. Antimicrob Agents Chemother. 2022;66: e0000322. https:\/\/doi.org\/10.1128\/aac.00003-22.","journal-title":"Antimicrob Agents Chemother"},{"key":"1455_CR19","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1007\/s11095-006-9116-0","volume":"23","author":"JH Proost","year":"2006","unstructured":"Proost JH, Eleveld DJ. Performance of an iterative two-stage Bayesian technique for population pharmacokinetic analysis of rich data sets. Pharm Res. 2006;23:2748\u201359. https:\/\/doi.org\/10.1007\/s11095-006-9116-0.","journal-title":"Pharm Res"},{"key":"1455_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.aca.2013.01.016","volume":"767","author":"P Fern\u00e1ndez","year":"2013","unstructured":"Fern\u00e1ndez P, Gonz\u00e1lez C, Pena MT, Carro AM, Lorenzo RA. A rapid ultrasound-assisted dispersive liquid-liquid microextraction followed by ultra-performance liquid chromatography for the simultaneous determination of seven benzodiazepines in human plasma samples. Anal Chim Acta. 2013;767:88\u201396. https:\/\/doi.org\/10.1016\/j.aca.2013.01.016.","journal-title":"Anal Chim Acta"},{"key":"1455_CR21","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jcph.2005","volume":"62","author":"KN Shudofsky","year":"2022","unstructured":"Shudofsky KN, Janssen PKC, Foudraine N, le Noble JLML. Clearance of lormetazepam, midazolam, and their conjugated metabolites by continuous venovenous hemofiltration during prolonged sedation in critically ill patients with COVID-19-associated acute respiratory distress syndrome. J Clin Pharmacol. 2022;62:568\u201370. https:\/\/doi.org\/10.1002\/jcph.2005.","journal-title":"J Clin Pharmacol"},{"key":"1455_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF03190123","volume":"15","author":"M Hildebrand","year":"1990","unstructured":"Hildebrand M, Hellstern A, H\u00fcmpel M, Hellenbrecht D, Saller R. Plasma levels and urinary excretion of lormetazepam in patients with liver cirrhosis and in healthy volunteers. Eur J Drug Metab Pharmacokinet. 1990;15:19\u201326. https:\/\/doi.org\/10.1007\/BF03190123.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1455_CR23","unstructured":"SmPc. Lormetazepam; 2019. Health Product Regulatory Authority. https:\/\/www.hpra.ie\/img\/uploaded\/swedocuments\/Licence_PA1410-009-001_14112019155952.pdf. Accessed 6 Mar 2024"},{"key":"1455_CR24","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1111\/bcp.13591","volume":"84","author":"R Ter Heine","year":"2018","unstructured":"Ter Heine R, van Erp NP, Guchelaar HJ, de Fijter JW, Reinders MEJ, van Herpen CM, et al. A pharmacological rationale for improved everolimus dosing in oncology and transplant patients. Br J Clin Pharmacol. 2018;84:1575\u201386. https:\/\/doi.org\/10.1111\/bcp.13591.","journal-title":"Br J Clin Pharmacol"},{"key":"1455_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/bcp.12550","volume":"79","author":"H Yu","year":"2015","unstructured":"Yu H, Steeghs N, Kloth JSL, de Wit D, van Hasselt JGC, van Erp NP, et al. Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662. Br J Clin Pharmacol. 2015;79:809\u201319. https:\/\/doi.org\/10.1111\/bcp.12550.","journal-title":"Br J Clin Pharmacol"},{"key":"1455_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/psp4.12318","volume":"7","author":"MJ van Esdonk","year":"2018","unstructured":"van Esdonk MJ, Lindeman I, Okkerse P, de Kam ML, Groeneveld GJ, Stevens J. Population pharmacokinetic\/pharmacodynamic analysis of nociceptive pain models following an oral pregabalin dose administration to healthy subjects. CPT Pharmacometrics Syst Pharmacol. 2018;7:573\u201380. https:\/\/doi.org\/10.1002\/psp4.12318.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"1455_CR27","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/08971900221100205","volume":"36","author":"J Forsberg","year":"2023","unstructured":"Forsberg J, Bedard E, Mahmoud SH. Bioavailability of orally administered drugs in critically ill patients. J Pharm Pract. 2023;36:967\u201379. https:\/\/doi.org\/10.1177\/08971900221100205.","journal-title":"J Pharm Pract"},{"key":"1455_CR28","first-page":"575","volume":"38","author":"M Grissinger","year":"2013","unstructured":"Grissinger M. Preventing errors when drugs are given via enteral feeding tubes. P T. 2013;38:575\u20136.","journal-title":"P T"},{"key":"1455_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.clnesp.2023.12.017","volume":"59","author":"M Kitayama","year":"2024","unstructured":"Kitayama M, Unoki T, Liu K, Nakamura K. Enteral nutrition practice in the prone position in patients with coronavirus disease 2019: An international one-day point prevalence analysis. Clin Nutr ESPEN. 2024;59:257\u201363. https:\/\/doi.org\/10.1016\/j.clnesp.2023.12.017.","journal-title":"Clin Nutr ESPEN."},{"key":"1455_CR30","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.apsb.2020.09.013","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Han Y, Huang W, Jin M, Gao Z. The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharm Sin B. 2021;11:1789\u2013812. https:\/\/doi.org\/10.1016\/j.apsb.2020.09.013.","journal-title":"Acta Pharm Sin B."},{"key":"1455_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41575-022-00698-4","volume":"20","author":"F Zhang","year":"2023","unstructured":"Zhang F, Lau RI, Liu Q, Su Q, Chan FKL, Ng SC. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nat Rev Gastroenterol Hepatol. 2023;20:323\u201337. https:\/\/doi.org\/10.1038\/s41575-022-00698-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1455_CR32","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/cpt.2698","volume":"112","author":"EC Le Carpentier","year":"2022","unstructured":"Le Carpentier EC, Canet E, Masson D, Martin M, Deslandes G, Gaultier A, et al. Impact of inflammation on midazolam metabolism in severe COVID-19 patients. Clin Pharmacol Ther. 2022;112:1033\u20139. https:\/\/doi.org\/10.1002\/cpt.2698.","journal-title":"Clin Pharmacol Ther"},{"key":"1455_CR33","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s40262-022-01122-5","volume":"61","author":"TJL Smeets","year":"2022","unstructured":"Smeets TJL, Valkenburg AJ, van der Jagt M, Koch BCP, Endeman H, Gommers DAMP, et al. Hyperinflammation reduces midazolam metabolism in critically ill adults with COVID-19. Clin Pharmacokinet. 2022;61:973\u201383. https:\/\/doi.org\/10.1007\/s40262-022-01122-5.","journal-title":"Clin Pharmacokinet"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-024-01455-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-024-01455-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-024-01455-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T14:10:36Z","timestamp":1734358236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-024-01455-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1455"],"URL":"https:\/\/doi.org\/10.1007\/s40262-024-01455-3","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"type":"print","value":"0312-5963"},{"type":"electronic","value":"1179-1926"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"31 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for conducting this study. Most of this study was performed as part of daily clinical routine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"N.P. discloses that he is the president of Medimatics, a company that provides MIPD consulting services in Maastricht, the Netherlands. The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All data supporting the findings of this study are available upon request from the corresponding author.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Permission to use the data was granted by the Medical Ethics Committee (azM\/UM, METC 2020-1339). The written informed consent requirement for observational studies was waived.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Upon request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors contributed to the conception and design of the study, and material preparation and data collection were performed by JN and KS. Pharmacokinetic analysis was performed by NP and PJ. The first draft of the manuscript was written by JN and KS. All authors commented on the previous versions of the manuscript. All the authors have read and approved the final version of this manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}